Want to see HK:1696 full AI Analyst Report?
1696 Stock Chart & Stats
HK$3.87
-HK$0.01(-0.28%)
At close: 4:00 PM EST
HK$3.87
-HK$0.01(-0.28%)
Day’s Range― - ―
52-Week RangeHK$1.88 - HK$6.24
Previous CloseN/A
Volume75.47K
Average Volume (3M)218.60K
Market Cap
HK$920.29M
Enterprise ValueHK$2.01K
Total Cash (Recent Filing)HK$77.27M
Total Debt (Recent Filing)HK$78.87M
Price to Earnings (P/E)10.2
Beta1.11
Next Earnings
Mar 24, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.88%
Share Statistics
EPS (TTM)0.02
Shares Outstanding468,343,080
10 Day Avg. Volume160,640
30 Day Avg. Volume218,605
Financial Highlights & Ratios
PEG Ratio-0.55
Price to Book (P/B)0.53
Price to Sales (P/S)0.69
P/FCF Ratio37.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.66
Revenue Forecast (FY)HK$3.17B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a growing equity base reduce financial risk and preserve flexibility for product development, market expansion, and customer support. This conservative funding structure gives Sisram greater resilience if demand softens or profitability takes longer to recover.
Long-Term Revenue GrowthThe company has expanded revenue over the longer period despite an uneven recent trajectory, indicating that its medical aesthetics portfolio continues to generate demand. A return to growth in 2025 provides a foundation for rebuilding earnings if execution and margins improve.
Recurring Revenue ModelCombining upfront device sales with consumables, maintenance, training, and technical support can deepen customer relationships and create revenue beyond the initial equipment purchase. A larger installed base may therefore support more durable monetization as deployed systems are used and serviced.
Bears Say
Margin CompressionSustained operating and net margin deterioration signals that revenue growth is translating into less profit, whether from higher costs, pricing pressure, or an unfavorable mix. If this trend persists, it can weaken reinvestment capacity and reduce the earnings benefit of future sales.
Weakening Cash GenerationThe sharp decline in operating and free cash flow reduces internally generated funding for research, commercial expansion, and shareholder returns. Although free cash flow remained positive, weak cash conversion and cash flow below net income raise concerns about the durability and quality of reported earnings.
Falling Earnings Per ShareA substantial decline in EPS indicates that shareholder earnings have contracted, even though revenue has continued to grow over the longer period. Continued per-share earnings pressure could limit capital allocation options and make it harder for the business to demonstrate operating leverage.
Sisram Medical Ltd. News
1696 FAQ
What was Sisram Medical Ltd.’s price range in the past 12 months?
Sisram Medical Ltd. lowest stock price was HK$1.88 and its highest was HK$6.24 in the past 12 months.
What is Sisram Medical Ltd.’s market cap?
Sisram Medical Ltd.’s market cap is HK$920.29M.
When is Sisram Medical Ltd.’s upcoming earnings report date?
Sisram Medical Ltd.’s upcoming earnings report date is Mar 24, 2027 which is in 183 days.
How were Sisram Medical Ltd.’s earnings last quarter?
Sisram Medical Ltd. released its earnings results on Aug 19, 2026. The company reported -HK$0.02 earnings per share for the quarter.
Is Sisram Medical Ltd. overvalued?
According to Wall Street analysts Sisram Medical Ltd.’s price is currently Overvalued.
Does Sisram Medical Ltd. pay dividends?
Sisram Medical Ltd. pays a Annually dividend of HK$0.095 which represents an annual dividend yield of 4.88%. See more information on Sisram Medical Ltd. dividends here
What is Sisram Medical Ltd.’s EPS estimate?
Sisram Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sisram Medical Ltd. have?
Sisram Medical Ltd. has 468,343,080 shares outstanding.
What happened to Sisram Medical Ltd.’s price movement after its last earnings report?
Sisram Medical Ltd. reported an EPS of -HK$0.02 in its last earnings report. Following the earnings report the stock price went down -2.729%.
Which hedge fund is a major shareholder of Sisram Medical Ltd.?
Currently, no hedge funds are holding shares in HK:1696
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sisram Medical Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.06%
12-Months-Change
Fundamentals
Return on Equity
4.88%
Trailing 12-Months
Asset Growth
4.79%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sisram Medical Ltd.
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
Technical Analysis
Peijia Medical Ltd.
―
Yestar Healthcare Holdings Co Ltd
―
Gaush Meditech Ltd.
―
Venus Medtech (Hangzhou), Inc. Class H
―
Austar Lifesciences Ltd.
―